Aurinia Pharmaceuticals (AUPH) Tax Rate (2020 - 2026)
Aurinia Pharmaceuticals' (AUPH) quarterly Tax Rate came in at 21.79% in Q1 2026, up 1766.0% YoY from 1.17% in Q1 2025, and up 104.44% on a QoQ basis from 490.62% in Q4 2025.
Powered by 
Analysis
Aurinia Pharmaceuticals (AUPH) Tax Rate (2020 - 2026) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 7 years of Tax Rate data on file, last reported at 21.79% in Q1 2026.
- Quarterly Tax Rate rose 1766.0% year-over-year to 21.79% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 123.03% (down 12771.0% YoY) and the FY2025 annual result came in at 151.59%, down 17436.0% from the prior year.
- Tax Rate improved to 21.79% in Q1 2026, from 490.62% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 51.15% in Q2 2024 to a low of 490.62% in Q4 2025.
- A 5-year average of 26.75% and a median of 0.03% in 2022 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2024 — Tax Rate soared 4586 bps — and 2025, when it sank 46471 bps.
- Tracing AUPH's Tax Rate over 5 years: stood at 3.28% in 2022, then jumped by 48 bps to 1.71% in 2023, then tumbled by 1418 bps to 25.92% in 2024, then tumbled by 1793 bps to 490.62% in 2025, then soared by 104 bps to 21.79% in 2026.
- The last three Tax Rate figures came in at 21.79% (Q1 2026), 490.62% (Q4 2025), and 1.25% (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Aurinia Pharmaceuticals | 2.10 Bn | 1.66 Bn | 76.67 Mn | 23.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.37% |
| Mar 31, 2026 | 21.86% |
| Dec 31, 2025 | -490.74% |
| Sep 30, 2025 | 1.29% |
| Jun 30, 2025 | 2.90% |
| Mar 31, 2025 | 4.13% |
| Dec 31, 2024 | -25.92% |
| Sep 30, 2024 | 3.38% |
| Jun 30, 2024 | 54.13% |
| Mar 31, 2024 | -7.38% |
| Dec 31, 2023 | -1.71% |
| Sep 30, 2023 | -2.28% |
| Jun 30, 2023 | 5.29% |
| Mar 31, 2023 | -1.69% |
| Dec 31, 2022 | -3.39% |
| Sep 30, 2022 | -11.87% |
| Jun 30, 2022 | -0.03% |
| Mar 31, 2022 | -0.03% |
| Dec 31, 2021 | -2.23% |
| Sep 30, 2021 | -0.02% |